Country Profile

Jordan

Jordan is a growing market for Indian pharmaceuticals — $64.6M in FY 2025–26. Medicine Ingredients accounts for 55% of shipments, with vaccines contributing $2.08M.

🇯🇴 $64.6M · 1.1× growth since FY2015 · 0.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$64.6M
Exports FY2025–26 DGCIS
1.1×
Growth FY2015→2026
0.5%
CAGR FY2015→2026
55%
Medicine Ingredients Share
5
Product Categories Supplied
Jordan is a growing market for Indian pharmaceuticals — $64.6M in FY 2025–26. Medicine Ingredients accounts for 55% of shipments, with vaccines contributing $2.08M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $35.7M (55.2%) Medicines $23.7M (36.7%) Surgical & Hospital Supplies $2.44M (3.8%) Vaccines $2.08M (3.2%) Traditional & Herbal $696K (1.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Jordan in the RBI overseas direct investment dataset (2011–2026).